D. Scott Neal’s Celgene Corp CELG Stock Holding History

D. Scott Neal’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-100	Closed	-$12K	–	177
2016 Q4	$12K	Hold	100	–	–	0.01%	114
2016 Q3	$10K	Buy	+100	New	+$10.8K	0.01%	113

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

D. Scott Neal's CELG Position: Q1 2017 in Review

D. Scott Neal sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 100 shares — an estimated $12K sold.

D. Scott Neal first reported a position in CELG in Q3 2016 and held it in 2 quarters. The position peaked at $12K in Q4 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

D. Scott Neal reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
D. Scott Neal sold 100 Celgene Corp shares in Q1 2017, an estimated $12K.
D. Scott Neal first reported a position in Celgene Corp in Q3 2016 and held it in 2 quarters.
D. Scott Neal's Celgene Corp position peaked at $12K in Q4 2016.
1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on D. Scott Neal's 13F filing for Q1 2017, filed 25 Apr 2017.